Readers of Dagogo-Jack and Santiago's1 excellent review of type 2 diabetes may be unaware that the embers of controversy regarding the effects of sulfonylureas on the heart in patients with type 2 diabetes, originally raised by the much maligned University Group Diabetes Program study,2 have been fanned by a series of basic science and animal experiments conducted over the past decade.3
Matz R. Sulfonylureas and Ischemic Heart Disease. Arch Intern Med. 1998;158(4):411–412. doi:
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.